Difficulty: Medium
Average Score: 86%
Practice
Which of the following agents is available as a patch for once-daily use and is likely to provide steady drug levels to treat Alzheimer's disease?
Correct answer
A
Rationale
Rivastigmine, an acetylcholinesterase inhibitor, treats Alzheimer's by increasing acetylcholine, improving cognition. Its transdermal patch delivers steady drug levels daily, minimizing peaks/troughs and reducing GI side effects (e.g., nausea) compared to oral forms, enhancing compliance. Donepezil, memantine, and galantamine are oral, lacking a once-daily patch; donepezil's long half-life mimics steady-state but isn't transdermal. Glatiramer treats MS, not Alzheimer's. Rivastigmine's patch formulation ensures consistent cholinergic enhancement, critical for sustained symptom relief in Alzheimer's, distinguishing it as the optimal choice here.